UNSW will lead a world-first study to evaluate the effectiveness of a
one tablet per day hepatitis C treatment as a means of preventing the
spread of the virus in prisons.
The SToP-C study (Surveillance
and Treatment of Prisoners with hepatitis C) is being undertaken in
collaboration with the Justice Health and Forensic Mental Health
Network, Corrective Services NSW, NSW Health, Hepatitis NSW, NSW Users
and AIDS Association, and the Community Restorative Centre.
study will begin recruiting prisoners in selected correctional
facilities in New South Wales starting in September 2014. UNSW
researchers and project partners will investigate whether a significant
reduction in hepatitis C infections in NSW prisons is possible with a
“treatment as prevention” strategy, which will seek to treat consenting
prisoners for their hepatitis C infection, both to improve their own
health and to make onward transmission to others less likely.